FindTrial
Sign In

Switch to bupropion

DRUG2 trials

Sponsors

Washington University School of Medicine, Centre for Addiction and Mental Health

Conditions

DementiaDepressionGeriatric DepressionLate Life DepressionMajor Depressive DisorderMild Cognitive ImpairmentTreatment Resistant DepressionTreatment-Refractory Depression

Phase 4

Optimizing Outcomes of Treatment-Resistant Depression in Older Adults
CompletedNCT02960763
Washington University School of MedicineGeriatric Depression, Late Life Depression, Major Depressive Disorder +2
Start: 2017-02-24End: 2021-09-01Updated: 2024-10-03
RCT of Brain Longitudinal Biomarker Study (OPT-Neuro RCT)
CompletedNCT05531591
Centre for Addiction and Mental HealthDementia, Depression, Geriatric Depression +5
Start: 2019-08-01End: 2024-07-31Updated: 2024-11-25

Related Papers

Cognitive changes in older adults receiving pharmacotherapy for treatment-resistant depression: a secondary analysis of the OPTIMUM randomised controlled trial.
2025-10-01
Antidepressant Augmentation versus Switch in Treatment-Resistant Geriatric Depression
New England Journal of Medicine2023-03-0365 citations